Schizophrenia and Disorders With Psychotic Features Clinical Trial
Official title:
Mindfulness-based Social Cognition Group Training (SocialMIND) Versus Psychoeducational Multicomponent Intervention in Patients With a First Episode of Psychosis (AGES-Mind Study): A Randomized Controlled Trial
The current investigation aims to compare two group intervention in patients with a first episode of psychosis, that is, people who have suffered their first psychotic episode within 5 years prior to their inclusion in the study. The experimental arm is a mindfulness-based social cognition training (SocialMind) designed by professionals with both formal training and clinical experience in the field of mindfulness and third generation cognitive-behavioral therapies. The active comparator arm is a psychoeducation program specifically designed for individuals with recent onset psychosis by members of the team with great experience in delivering such interventions. The main outcome is social functioning, as measured by the Personal and Social Performance Scale (PSP), an instrument developed for psychotic patients. The main hypothesis is that the improvement in social functioning will be larger among the participants on the experimental arm, because there is enough evidence suggesting that deficits in social cognition are present even in the first stages of psychotic syndrome and related to social functioning and general disability. Moreover, mindfulness-based interventions have proven themselves effective in other severe mental disorders.
Social functioning is impaired among many patients with a first episode of psychosis, who also show a lower ability to recognize, understand and benefit from social stimuli (i.e., deficits in social cognition) than their pairs. Both deficits underlie the general functional impairment found across non-affective psychotic syndromes. Since currently available pharmacological strategies have not proven themselves effective in addressing this matter, new psychotherapeutic approaches should be developed. Investigators' main hypothesis is that a mindfulness-based social cognition group training (SocialMind) will improve social and general functioning, and that this improvement will be higher in the SocialMind than in the psychoeducation group. Given the association between oxidative stress and cognitive functioning, a relationship between oxidative stress biomarkers and intervention-related variables is also expected. A research team with more than ten mental health professionals and many collaborators will carry and oversee the assessment sessions. A Pharmacology Department will analyse the biological samples. Regulated-trained, well-experienced clinicians will design and administer both interventions. The whole team will take part in the process of scientific publication and results dissemination. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01196858 -
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
|
N/A | |
| Completed |
NCT00136760 -
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
|
Phase 2 | |
| Not yet recruiting |
NCT01968161 -
Investigator Initiated Study - Asenapine Early Psychosis
|
Phase 4 | |
| Completed |
NCT00135772 -
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
|
N/A | |
| Completed |
NCT02308462 -
Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents
|
N/A | |
| Completed |
NCT03133143 -
Video Games Among People With Schizophrenia
|
N/A | |
| Completed |
NCT00309452 -
Specialized Treatment Early in Psychosis (STEP)
|
N/A | |
| Not yet recruiting |
NCT02240173 -
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
|
Phase 1/Phase 2 | |
| Completed |
NCT00218218 -
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
|
Phase 2 | |
| Completed |
NCT02321943 -
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
|
N/A | |
| Completed |
NCT02928965 -
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
|
Phase 2 | |
| Completed |
NCT02307396 -
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
|
Phase 4 | |
| Terminated |
NCT00748566 -
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
|
Phase 4 | |
| Recruiting |
NCT00791882 -
Social Skills Training in Refractory Schizophrenia
|
N/A | |
| Completed |
NCT00363181 -
Side Effects of Antipsychotic Medications
|
||
| Completed |
NCT00137189 -
Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
|
N/A |